Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 26: 1354-1356, 1980;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, R. T.

Clinical Chemistry, Vol 26, 1354-1356, Copyright © 1980 by American Association for Clinical Chemistry

Effect of in vitro hemolysis on assay of plasma catecholamines and DOPA

RT Smith

I analyzed for free and sulfate-conjugated catecholamines and DOPA (3,4- dihydroxyphenylalanine) in four aliquots of a single plasma pool with use of Upjohn's "Cat-A-Kit" (catecholamines radioenzymatic assay kit [3H]. One aliquot was a clear plasma control; the others were supplemented with different concentrations of lysed human erythrocytes, to investigate possible interference by hemolysis with analysis for norepinephrine, epinephrine, dopamine, or DOPA in plasma. I observed no statistically significant difference that could be attributed to the degree of hemolysis between control and treatment groups for DOPA or any catecholamine fraction. Hemolysis in plasma from improper collection or processing techniques apparently does not preclude accurate and precise quantitation of free or sulfate-conjugated catecholamines or DOPA with the Cat-A-Kit.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Association for Clinical Chemistry.